Testicular Cancer

For a suspicious intratesticular mass, proceed with radical inguinal orchiectomy as the initial diagnostic and therapeutic procedure. This provides histology and separates seminoma from nonseminomatous or mixed germ cell tumor, the distinction that drives postorchiectomy risk assessment and treatment selection. ScienceDirect+1ScienceDirectLong-term endocrine sequelae in testicular cancerJAMATesticular Germ Cell Tumors: A Review

Draw AFP, beta-hCG, and LDH before orchiectomy and trend them after surgery as part of staging and response assessment. A case of pure seminoma reported negative AFP and beta-hCG with elevated LDH, illustrating that marker-negative disease does not exclude metastatic germ cell cancer and that testicular ultrasound may identify an occult testicular primary despite an unrevealing examination. BMJ+1BMJRapid responses - Managing testicular cancerBMJMuscle weakness with a hidden cause

After orchiectomy, use histology, postorchiectomy serum-marker status, and cross-sectional staging to assign clinical stage and determine whether the patient has stage I disease appropriate for surveillance or risk-adapted adjuvant treatment versus metastatic disease requiring systemic therapy. Contemporary guidance covers diagnosis, treatment, and follow-up across these decisions. ESMO+1ESMOESMO Clinical Practice Guideline: Testicular CancerESMOESMO Clinical Practice Guidelines: Genitourinary Cancers

Clinical stage I NSGCT is commonly managed with surveillance or adjuvant chemotherapy; RPLND has a limited role. About 70% of patients are cured with orchiectomy alone, so immediate treatment exposes many patients to toxicity they would not otherwise need. uroweburowebDisease Management - EAU Guidelines on Testicular Cancer - Uroweb

Use lymphovascular invasion as the principal cited pathologic relapse discriminator. Historical relapse estimates are approximately 50% with lymphovascular invasion and 15% without it. Discuss these risks explicitly alongside the patient's ability and willingness to complete surveillance, comorbidities, reproductive goals, and tolerance for delayed treatment if relapse occurs. uroweburowebDisease Management - EAU Guidelines on Testicular Cancer - Uroweb

When a patient with stage I NSGCT declines surveillance or cannot reliably comply with it, discuss one course of cisplatin, etoposide, and bleomycin as adjuvant therapy. The cited guideline identifies this as an alternative to surveillance; it does not establish a dose schedule in the available material. uroweburowebDisease Management - EAU Guidelines on Testicular Cancer - Uroweb

Reserve nerve-sparing RPLND for highly selected stage I NSGCT patients who have a contraindication to adjuvant chemotherapy and are unwilling to undergo surveillance. The procedure must be balanced against operative morbidity, whereas avoiding chemotherapy may reduce long-term systemic toxicity. uroweb+1urowebDisease Management - EAU Guidelines on Testicular Cancer - UrowebScienceDirectManagement of a challenging case of post chemotherapy ...

Metastatic testicular germ cell tumors remain among the most curable solid malignancies because of their sensitivity to cisplatin-based combination regimens. Reported overall cure rates exceed 95% across testicular cancer, with cure estimates around 80% for metastatic disease in the cited review. JAMAJAMAMedical Treatment of Advanced Testicular Cancer | Oncology

Treat metastatic disease through a multidisciplinary urologic oncology and medical oncology pathway. Cisplatin-based combination chemotherapy is the central systemic modality; BEP is identified as a conventional platinum-based regimen, and an alternative bleomycin-free approach has emerged for selected patients with metastatic poor-prognosis disease. Nature+2NatureTesticular Germ Cell Tumor Management and TreatmentNatureTesticular cancer | Nature Reviews UrologyScienceDirectComplex treatment of residual metastatic germ cell cancer

Plan residual-disease management before starting chemotherapy. Postchemotherapy RPLND is a recommended surgical treatment for NSGCT, and residual masses may require complex multidisciplinary surgical care after systemic treatment. ScienceDirect+1ScienceDirectManagement of a challenging case of post chemotherapy ...ScienceDirectComplex treatment of residual metastatic germ cell cancer

For seminoma, distinguish a pure seminoma marker pattern from nonseminomatous disease but do not assume normal AFP or beta-hCG excludes tumor burden. In the reported occult-primary case, extensive retroperitoneal metastatic pure seminoma presented with negative AFP and beta-hCG, while ultrasound subsequently identified a hypoechoic testicular lesion. BMJBMJMuscle weakness with a hidden cause

Follow patients using the management pathway appropriate to histology, stage, and treatment; testicular cancer guidelines explicitly address diagnosis, treatment, and follow-up. Serum AFP, beta-hCG, and LDH are clinically useful longitudinal data when initially elevated or when disease biology supports marker monitoring, but normal markers do not substitute for imaging and examination in marker-negative disease. BMJ+2BMJRapid responses - Managing testicular cancerBMJMuscle weakness with a hidden causeESMOESMO Clinical Practice Guideline: Testicular Cancer

At every survivorship transition, document prior cisplatin, bleomycin, radiotherapy, and RPLND exposure because each changes the late-effect differential. Platinum-based chemotherapy and radiotherapy are associated with cardiovascular disease, ototoxicity, and secondary malignancies, while RPLND carries surgical risks but avoids long-term systemic exposure. ScienceDirectScienceDirectManagement of a challenging case of post chemotherapy ...

Counsel stage I patients that the management objective is not simply minimizing recurrence; it is minimizing lifetime treatment burden while preserving cure. Long-term survival in stage I germ cell tumor is approximately 99%, making overtreatment and late toxicity central considerations in initial shared decision-making. NatureNatureTesticular cancer | Nature Reviews Urology